WILMINGTON, DE — Incyte (Nasdaq: INCY) announced plans to participate in several investor conferences throughout September 2025.
The company will present at the Cantor Global Healthcare Conference on September 3 at 8:00 a.m. EDT, followed by the Wells Fargo Healthcare Conference on September 4 at 8:45 a.m. EDT. Incyte will also speak at the Morgan Stanley 23rd Annual Global Healthcare Conference on September 9 at 10:00 a.m. EDT.
The presentations will be webcast live via Incyte’s investor website and available for replay for 30 days.
Headquartered in Wilmington, Delaware, Incyte is a global biopharmaceutical company focused on discovering, developing, and commercializing proprietary therapeutics. The company’s portfolio includes first-in-class medicines and a robust pipeline targeting oncology, inflammation, and autoimmunity, with operations spanning North America, Europe, and Asia.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.